{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T11:23:56Z","timestamp":1778671436838,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T00:00:00Z","timestamp":1736035200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9lius Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["COVID-19-RECPLAS"],"award-info":[{"award-number":["COVID-19-RECPLAS"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010135","name":"Finska L\u00e4kares\u00e4llskapet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010135","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009033","name":"NHS Blood and Transplant","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Research Council of Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004155","name":"Magnus Ehrnrooth Fundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004155","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jinf.2025.106412","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T11:40:29Z","timestamp":1736422829000},"page":"106412","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Individual patient and donor seroprofiles in convalescent plasma treatment of COVID-19 in REMAP-CAP clinical trial"],"prefix":"10.1016","volume":"90","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8052-5592","authenticated-orcid":false,"given":"Visa","family":"Nurmi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Mayne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1251-4404","authenticated-orcid":false,"given":"Chanice","family":"Knight","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannia L.","family":"Almonacid-Mendoza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shannah","family":"Secret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lise","family":"Estcourt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jussi","family":"Hepojoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ton\u0107i","family":"\u0160u\u0161ti\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9287-2177","authenticated-orcid":false,"given":"Abigail A.","family":"Lamikanra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoi Pat","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3228-9692","authenticated-orcid":false,"given":"David K.","family":"Menon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manu","family":"Shankar-Hari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Ellen","family":"van der Schoot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gestur","family":"Vidarsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Simmonds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Hedman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heli","family":"Harvala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7798","key":"10.1016\/j.jinf.2025.106412_bib1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.jinf.2025.106412_bib2","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJMoa2034545","article-title":"Antibody status and incidence of SARS-CoV-2 infection in health care workers","volume":"384","author":"Lumley","year":"2021","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.jinf.2025.106412_bib3","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection","volume":"27","author":"Khoury","year":"2021","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.jinf.2025.106412_bib4","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMoa2033700","article-title":"Early high-titer plasma therapy to prevent severe Covid-19 in older adults","volume":"384","author":"Libster","year":"2021","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.jinf.2025.106412_bib5","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1056\/NEJMoa2119657","article-title":"Early outpatient treatment for Covid-19 with convalescent plasma","volume":"386","author":"Sullivan","year":"2022","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jinf.2025.106412_bib6","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-021-06829-7","article-title":"Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials","volume":"21","author":"Axfors","year":"2021","journal-title":"BMC Infect Dis"},{"issue":"10289","key":"10.1016\/j.jinf.2025.106412_bib7","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/S0140-6736(21)00897-7","article-title":"Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial","volume":"397","author":"Abani","year":"2021","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.jinf.2025.106412_bib8","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1038\/s41591-021-01488-2","article-title":"Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial","volume":"27","author":"B\u00e9gin","year":"2021","journal-title":"Nat Med"},{"issue":"17","key":"10.1016\/j.jinf.2025.106412_bib9","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1001\/jama.2021.18178","article-title":"Effect of convalescent plasma on organ support-free days in critically ill patients with COVID-19: a randomized clinical trial","volume":"326","author":"Estcourt","year":"2021","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.jinf.2025.106412_bib10","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.cmi.2024.07.020","article-title":"Convalescent plasma and predictors of mortality among hospitalized patients with COVID-19: a systematic review and meta-analysis","volume":"30","author":"Franchini","year":"2024","journal-title":"Clin Microbiol Infect"},{"issue":"10325","key":"10.1016\/j.jinf.2025.106412_bib11","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(22)00163-5","article-title":"Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial","volume":"399","author":"Abani","year":"2022","journal-title":"Lancet"},{"issue":"30","key":"10.1016\/j.jinf.2025.106412_bib12","doi-asserted-by":"crossref","first-page":"26733","DOI":"10.1074\/jbc.M202069200","article-title":"Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity","volume":"277","author":"Shields","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jinf.2025.106412_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00877","article-title":"Decoding the human immunoglobulin G-glycan repertoire reveals a spectrum of Fc-receptor- and complement-mediated-effector activities","volume":"8","author":"Dekkers","year":"2017","journal-title":"Front Immunol"},{"issue":"6532","key":"10.1016\/j.jinf.2025.106412_bib14","doi-asserted-by":"crossref","DOI":"10.1126\/science.abc8378","article-title":"Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity","volume":"371","author":"Larsen","year":"2021","journal-title":"Science"},{"issue":"596","key":"10.1016\/j.jinf.2025.106412_bib15","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abf8654","article-title":"High titers and low fucosylation of early human anti-SARS-CoV-2 IgG promote inflammation by alveolar macrophages","volume":"13","author":"Hoepel","year":"2021","journal-title":"Sci Transl Med"},{"issue":"7914","key":"10.1016\/j.jinf.2025.106412_bib16","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41586-022-04702-4","article-title":"Fc\u03b3R-mediated SARS-CoV-2 infection of monocytes activates inflammation","volume":"606","author":"Junqueira","year":"2022","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.jinf.2025.106412_bib17","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1182\/blood-2008-03-144600","article-title":"Antibody fucosylation differentially impacts cytotoxicity mediated by NK and PMN effector cells","volume":"112","author":"Peipp","year":"2008","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jinf.2025.106412_bib18","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1093\/infdis\/jiad568","article-title":"Vaccine-boosted CCP decreases virus replication and hastens resolution of infection despite transiently enhancing disease in SARS-CoV-2-infected hamsters","volume":"229","author":"Carroll","year":"2024","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.jinf.2025.106412_bib19","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1111\/trf.16934","article-title":"Convalescent plasma donors show enhanced cross-reactive neutralizing antibody response to antigenic variants of SARS-CoV-2 following immunization","volume":"62","author":"Harvala","year":"2022","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.jinf.2025.106412_bib20","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/infdis\/jiad070","article-title":"The relationship between SARS-CoV-2 neutralizing antibody titers and avidity in plasma collected from convalescent nonvaccinated and vaccinated blood donors","volume":"228","author":"Nurmi","year":"2023","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2025.106412_bib21","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/infdis\/jiab283","article-title":"Virological characterization of critically ill patients with COVID-19 in the United Kingdom: interactions of viral load, antibody status, and B.1.1.7 infection","volume":"224","author":"Ratcliff","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2025.106412_bib22","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ijid.2021.05.047","article-title":"Comparison of approaches for IgG avidity calculation and a new highly sensitive and specific method with broad dynamic range","volume":"110","author":"Nurmi","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"2","key":"10.1016\/j.jinf.2025.106412_bib23","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3390\/v13020143","article-title":"A 10-minute \u201cMix and Read\u201d antibody assay for SARS-CoV-2","volume":"13","author":"Rusanen","year":"2021","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.jinf.2025.106412_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010265","article-title":"A protease-activatable luminescent biosensor and reporter cell line for authentic SARS-CoV-2 infection","volume":"18","author":"Gerber","year":"2022","journal-title":"PLoS Pathog"},{"issue":"3","key":"10.1016\/j.jinf.2025.106412_bib25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/tme.12746","article-title":"Convalescent plasma therapy for the treatment of patients with COVID\u201019: assessment of methods available for antibody detection and their correlation with neutralising antibody levels","volume":"31","author":"Harvala","year":"2021","journal-title":"Transfus Med"},{"key":"10.1016\/j.jinf.2025.106412_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104109","article-title":"Immunoassay for quantification of antigen-specific IgG fucosylation","volume":"81","author":"\u0160u\u0161ti\u0107","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jinf.2025.106412_bib27","doi-asserted-by":"crossref","unstructured":"McKinney Wes. Data Structures for Statistical Computing in Python. In Proceedings of the 9th Python in Science Conference 2010:56\u201361. Doi: 10.25080\/MAJORA-92BF1922-00A.","DOI":"10.25080\/Majora-92bf1922-00a"},{"key":"10.1016\/j.jinf.2025.106412_bib28","first-page":"2825","article-title":"Scikit-learn: Machine Learning in Python","volume":"12","author":"Fabian","year":"2011","journal-title":"J Mach Learn Res"},{"issue":"3","key":"10.1016\/j.jinf.2025.106412_bib29","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1037\/met0000074","article-title":"An empirical Kaiser criterion","volume":"22","author":"Braeken","year":"2017","journal-title":"Psychol Methods"},{"issue":"1","key":"10.1016\/j.jinf.2025.106412_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13063-022-06097-z","article-title":"Planning a method for covariate adjustment in individually randomised trials: a practical guide","volume":"23","author":"Morris","year":"2022","journal-title":"Trials"},{"issue":"3","key":"10.1016\/j.jinf.2025.106412_bib31","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/sim.9969","article-title":"Inverse probability of treatment weighting with generalized linear outcome models for doubly robust estimation","volume":"43","author":"Gabriel","year":"2024","journal-title":"Stat Med"},{"issue":"17","key":"10.1016\/j.jinf.2025.106412_bib32","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1056\/NEJMoa2209502","article-title":"Convalescent plasma for Covid-19-induced ARDS in mechanically ventilated patients","volume":"389","author":"Beno\u00eet","year":"2023","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jinf.2025.106412_bib33","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.mayocpiqo.2023.09.001","article-title":"Rates among hospitalized patients with COVID-19 treated with convalescent plasma: a systematic review and meta-analysis","volume":"7","author":"Senefeld","year":"2023","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"issue":"24","key":"10.1016\/j.jinf.2025.106412_bib34","doi-asserted-by":"crossref","DOI":"10.1172\/JCI155114","article-title":"A randomized controlled study of convalescent plasma for individuals hospitalized with COVID-19 pneumonia","volume":"131","author":"Bar","year":"2021","journal-title":"J Clin Invest"},{"issue":"13","key":"10.1016\/j.jinf.2025.106412_bib35","doi-asserted-by":"crossref","DOI":"10.1172\/JCI150646","article-title":"A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19","volume":"131","author":"O\u2019Donnell","year":"2021","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.jinf.2025.106412_bib36","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.178460","article-title":"Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trial","volume":"9","author":"Park","year":"2024","journal-title":"JCI Insight"},{"issue":"2","key":"10.1016\/j.jinf.2025.106412_bib37","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41579-022-00809-7","article-title":"SARS-CoV-2 variant evasion of monoclonal antibodies based on in vitro studies","volume":"21","author":"Cox","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jinf.2025.106412_bib38","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/s00134-022-06869-w","article-title":"Coronavirus disease 2019 subphenotypes and differential treatment response to convalescent plasma in critically ill adults: secondary analyses of a randomized clinical trial","volume":"48","author":"Fish","year":"2022","journal-title":"Intensive Care Med"},{"issue":"3","key":"10.1016\/j.jinf.2025.106412_bib39","doi-asserted-by":"crossref","first-page":"326","DOI":"10.4161\/mabs.19941","article-title":"Quantitative evaluation of fucose reducing effects in a humanized antibody on Fc\u03b3 receptor binding and antibody-dependent cell-mediated cytotoxicity activities","volume":"4","author":"Chung","year":"2012","journal-title":"MAbs"},{"issue":"1","key":"10.1016\/j.jinf.2025.106412_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-21463-2","article-title":"Antibody affinity maturation and plasma IgA associate with clinical outcome in hospitalized COVID-19 patients","volume":"12","author":"Tang","year":"2021","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.jinf.2025.106412_bib41","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/j.immuni.2021.06.015","article-title":"Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variants","volume":"54","author":"Moriyama","year":"2021","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.jinf.2025.106412_bib42","doi-asserted-by":"crossref","first-page":"599","DOI":"10.7326\/0003-4819-145-8-200610170-00139","article-title":"Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?","volume":"145","author":"Luke","year":"2006","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.jinf.2025.106412_bib43","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0163-4453(87)92603-X","article-title":"Prevention of hepatitis B infection in health care workers after accidental exposure","volume":"15","author":"Palmovi\u0107","year":"1987","journal-title":"J Infect"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445325000064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445325000064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T11:00:10Z","timestamp":1778670010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445325000064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0163445325000064"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2025.106412","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Individual patient and donor seroprofiles in convalescent plasma treatment of COVID-19 in REMAP-CAP clinical trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2025.106412","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of The British Infection Association.","name":"copyright","label":"Copyright"}],"article-number":"106412"}}